Biggest News Aggregation in the World
📰 Akrbp News

Page 2 - Akrbp News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Akrbp. Real-time updates on events, politics, business and more.

Short Interest in Kiromic BioPharma, Inc. (NASDAQ:KRBP) Declines By 41.6%

Kiromic BioPharma, Inc. (NASDAQ:KRBP – Get Rating) was the target of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 55,700 shares, a drop of 41.6% from the April 30th total of 95,400 shares. Based on an average trading volume of 348,900 shares, the […]
Kiromic Biopharma Kiromic Biopharma Inc Zacks Investment Research Blackrock Inc Intellectus Partners J Harrison Partners Inc

Zacks Investment Research Downgrades Kiromic BioPharma (NASDAQ:KRBP) to Sell

Kiromic BioPharma (NASDAQ:KRBP – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Wednesday, Zacks.com reports. According to Zacks, “Kiromic BioPharma Inc. is a discovery and gene-editing company utilizing artificial intelligence and a proprietary neural network platform with a therapeutic focus on […]
United States Kiromic Biopharma Kiromic Biopharma Inc Zacks Investment Research Renaissance Technologies J Harrison Partners Inc

Kiromic BioPharma, Inc. (NASDAQ:KRBP) to Post Q1 2023 Earnings of ($0.43) Per Share, Diamond Equity Forecasts

Kiromic BioPharma, Inc. (NASDAQ:KRBP – Get Rating) – Equities researchers at Diamond Equity issued their Q1 2023 earnings per share (EPS) estimates for shares of Kiromic BioPharma in a research report issued to clients and investors on Thursday, May 19th. Diamond Equity analyst H. Diamond forecasts that the company will post earnings of ($0.43) per […]
Kiromic Biopharma Kiromic Biopharma Inc J Harrison Partners Inc Warberg Asset Management Renaissance Technologies Kiromic Biopharma Company Profile Get Rating

Kiromic BioPharma, Inc. (NASDAQ:KRBP) Sees Significant Growth in Short Interest

Kiromic BioPharma, Inc. (NASDAQ:KRBP – Get Rating) was the recipient of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 333,000 shares, a growth of 216.5% from the February 28th total of 105,200 shares. Based on an average daily trading volume, of 296,500 shares, […]
Kiromic Biopharma Kiromic Biopharma Inc Capital Management Intellectus Partners Kiromic Biopharma Company Profile Get Rating Vanguard Group Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science